Amount Raised
$225 Million
Round Type
Post-IPO Equity
StamfordBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that it has entered into a securities purchase agreement with a select group of institutional investors to issue and sell an aggregate of 8,625,520 shares of its common stock at a price per share of $26.01 in a private placement transaction (the “Financing”). SpringWorks anticipates gross proceeds from the Financing to be approximately $225 million, before deducting offering expenses. The closing of the financing is expected to occur on September 9, 2022, subject to customary closing conditions.
Quick answer
SpringWorks raised $225 Million in a Post-IPO Equity round, dated September 7, 2022. SpringWorks is based in Stamford, Connecticut, United States.
- How much did SpringWorks raise?
- SpringWorks raised $225 Million in a Post-IPO Equity round on September 7, 2022.
- What does SpringWorks do?
- SpringWorks has a differentiated targeted oncology pipeline spanning solid tumors and hematological cancers, including two potentially registrational clinical trials in rare tumor types as well as several programs..
- Where is SpringWorks based and how big is it?
- SpringWorks is based in Stamford, Connecticut, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as SpringWorks that raised within 45 days of this round, from Fundz verified event records.
- CASI Pharmaceuticals raised an undisclosed amount on September 23, 2022.
- Abivax raised $49M (Funding Round) on September 2, 2022.
- LumaBridge raised an undisclosed amount (Private Equity) on August 23, 2022.
- Pharnext raised an undisclosed amount (Debt Financing) on October 3, 2022.
- Qnovia raised $17M (Series A) on September 28, 2022.
- Damona Pharmaceuticals raised $5.5M (Seed) on September 28, 2022.
Who to call at SpringWorks, and when
A new round usually means SpringWorks is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day SpringWorks raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at SpringWorks, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at SpringWorks. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment SpringWorks raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
SpringWorks raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.